DEF 14A

Company

TScan Therapeutics, Inc.

Filed

April 25, 2023

Period of Report

June 13, 2023

Accession Number

0001193125-23-114116

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →